Search in SEGM

Conferences (1)

CME (4)

Spotlight (60)

Studies (60)

Media (4)

Other (1)

Sort by

In March 2024, NHS England (NHSE) updated its puberty blockers and cross-sex hormones policies for gender-dysphoric youth. The release of these policies coincides with the launch of the new service model, which will replace the Gender Identity Development Service (GIDS) at Tavistock as of April 1,...

Matched fragments:

… NHS England (NHSE) updated its puberty blockers and cross-sex hormones … ( 10 documents regarding the puberty blocker policy and 1 for the … NHS England will no longer allow puberty blockers for gender …

Italy's National Bioethics Committee (CNB) updated its stance on the use of puberty blockers to treat gender dysphoria. The November 2024 guidance states that puberty blockers should only be provided after...

Matched fragments:

… updated its stance on the use of puberty blockers to treat gender dysphoria. … 2024 guidance states that puberty blockers should only be … of treatment and restrictions on puberty blockers to controlled trials …

The Society for Evidence-Based Gender Medicine (SEGM) maintains that treatments for gender-dysphoric people should be supported by high quality evidence. We commend the thorough process undertaken by the UK High Court to assess the ability of young people to consent to treatment that has serious...

Matched fragments:

… determined that the provision of puberty blocking medications (GnRHa) to stop normally-timed puberty in gender dysphoric young … ). The judges recognized puberty blockers as the first step in a …

Update May 08, 2021. The Karolinska Hospital in Sweden recently issued a new policy statement regarding treatment of gender-dysphoric minors. This policy, affecting Karolinska's pediatric gender services at Astrid Lindgren Children's Hospital (ALB), has ended the practice of prescribing puberty...

Matched fragments:

… ended the practice of prescribing puberty blockers and cross-sex hormones to … minors are treated with puberty blockers at age 12 (and in … ended the practice of prescribing puberty blockers and cross-sex …

New systematic reviews reveal that GnRH agonists lead to little or no change in gender dysphoria, mental health, body image and psychosocial functioning. All the studies evaluated had results of “very low” certainty, and were subject to bias and confounding.

Matched fragments:

… of GnRH agonists (also known as "puberty blockers") and cross-sex hormones as … The review of GnRH agonists (puberty blockers) makes for …

Suppressing puberty in children suffering from gender dysphoria — by administering Gonadotropin-Releasing Hormone agonist (GnRHa) — entails several known risks. One is that patients could “end with a decreased bone density, which is associated with a high risk of osteoporosis” (Delemarre-van de...

Matched fragments:

… Suppressing puberty in children suffering from … the judicial review into puberty suppression at the Tavistock … by children undergoing puberty suppression. Biggs cites an …

A new peer-reviewed article published in the Archives of Sexual Behavior examines the clinical and ethical implications of puberty blockers for children with gender dysphoria through the lens of “the child’s right to...

Matched fragments:

… and ethical implications of puberty blockers for children with gender … a normal physiological process of puberty is viewed as a disease that …

The Department of Health and Human Services recently proposed a slate of regulations that would effectively ban hospitals from using puberty blockers for children, citing research that shows the drugs can cause irreversible harm. Activist groups decried the move, claiming that puberty blockers—when...

Matched fragments:

… ban hospitals from using puberty blockers for children, citing … decried the move, claiming that puberty blockers—when prescribed to … ban hospitals from using puberty blockers for children, …

A recent study published in The Journal of Sexual Medicine reported demographic and treatment trends among gender-...

Matched fragments:

… — but for those who desire them, puberty blockers, cross-sex hormones and … for evaluation or treatment with puberty blockers. This retrospective …

Studies in the field of gender medicine are notoriously unreliable, plagued by small samples, lack of controls, confounding, and bias. This is true for even the “best” studies in the field, such as the “Dutch study”—...

Matched fragments:

… of the evidence for the use of puberty blockers for youth with gender … the evidence base for the use of puberty blockers. We find that Rew … review of evidence of using puberty blockers (GnRH analogues) to …

Search results

NHS England Stops Prescribing Puberty Blockers and Updates its Cross-Sex Hormones Policy for Minors

Italy Joins the List of Countries Recommending Restrictions on Puberty Blockers for Gender Dysphoria

UK High Court Ruling on the Use of Puberty Blockers in Gender Dysphoric Minors (Bell v. Tavistock)

Sweden’s Karolinska Ends All Use of Puberty Blockers and Cross-Sex Hormones for Minors Outside of Clinical Studies

New Systematic Reviews of Puberty Blockers and Cross-Sex Hormones Published by NICE

The Effect of Puberty Blockers on the Accrual of Bone Mass

Puberty Suppression for Pediatric Gender Dysphoria and the Child’s Right to an Open Future

Puberty Blockers Aren’t Curing Gender Dysphoria. They’re Manufacturing It

New "20-year" Study from Amsterdam's VUmc Youth Gender Clinic: A Critical Analysis

Commentary: The Signal and the Noise—questioning the benefits of puberty blockers for youth with gender dysphoria—a commentary on Rew et al. (2021)